Ming‐Ying Shang

2.0k total citations
85 papers, 1.8k citations indexed

About

Ming‐Ying Shang is a scholar working on Molecular Biology, Complementary and alternative medicine and Pharmacology. According to data from OpenAlex, Ming‐Ying Shang has authored 85 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 32 papers in Complementary and alternative medicine and 26 papers in Pharmacology. Recurrent topics in Ming‐Ying Shang's work include Traditional Chinese Medicine Analysis (24 papers), Natural product bioactivities and synthesis (24 papers) and Nephrotoxicity and Medicinal Plants (17 papers). Ming‐Ying Shang is often cited by papers focused on Traditional Chinese Medicine Analysis (24 papers), Natural product bioactivities and synthesis (24 papers) and Nephrotoxicity and Medicinal Plants (17 papers). Ming‐Ying Shang collaborates with scholars based in China, Japan and United States. Ming‐Ying Shang's co-authors include Shao‐Qing Cai, Feng Xu, Xuan Wang, Guang‐Xue Liu, Rufeng Wang, Jing Liang, Xinyu Zang, Donghui Yang, Jie Yu and Chao‐Mei Ma and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Journal of Chromatography A and British Journal of Pharmacology.

In The Last Decade

Ming‐Ying Shang

82 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming‐Ying Shang China 25 867 507 477 425 293 85 1.8k
Zhitao Liang Hong Kong 27 1.1k 1.2× 489 1.0× 596 1.2× 593 1.4× 283 1.0× 81 2.0k
Rui‐Chao Lin China 23 844 1.0× 302 0.6× 377 0.8× 310 0.7× 170 0.6× 69 1.6k
Xiaodong Wen China 30 1.3k 1.5× 481 0.9× 478 1.0× 315 0.7× 180 0.6× 78 2.2k
Renée Vanhaelen‐Fastré Belgium 19 565 0.7× 665 1.3× 376 0.8× 474 1.1× 365 1.2× 81 2.0k
Eike Reich Switzerland 22 562 0.6× 217 0.4× 283 0.6× 466 1.1× 293 1.0× 65 1.5k
Kee Dong Yoon South Korea 24 947 1.1× 240 0.5× 146 0.3× 326 0.8× 164 0.6× 73 1.6k
Shao‐Qing Cai China 38 2.2k 2.5× 983 1.9× 848 1.8× 974 2.3× 524 1.8× 169 4.0k
Peishan Xie China 17 1.3k 1.5× 379 0.7× 1.2k 2.5× 599 1.4× 693 2.4× 35 2.2k
Takashi Hakamatsuka Japan 21 620 0.7× 258 0.5× 195 0.4× 356 0.8× 74 0.3× 114 1.7k
Young Sup Kim South Korea 29 901 1.0× 274 0.5× 249 0.5× 434 1.0× 55 0.2× 54 1.9k

Countries citing papers authored by Ming‐Ying Shang

Since Specialization
Citations

This map shows the geographic impact of Ming‐Ying Shang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Ying Shang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Ying Shang more than expected).

Fields of papers citing papers by Ming‐Ying Shang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming‐Ying Shang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Ying Shang. The network helps show where Ming‐Ying Shang may publish in the future.

Co-authorship network of co-authors of Ming‐Ying Shang

This figure shows the co-authorship network connecting the top 25 collaborators of Ming‐Ying Shang. A scholar is included among the top collaborators of Ming‐Ying Shang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming‐Ying Shang. Ming‐Ying Shang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yang, Liqing Wang, Yang Lv, et al.. (2025). IdenHerb: A strategy for identifying constitutive herbs of herbal products by screening exclusive ions of each herb from large-scale multi-group LC–MS data. Journal of Chromatography A. 1743. 465716–465716. 1 indexed citations
2.
Xu, Feng, Yanfei Huang, Hong‐Fu Li, et al.. (2024). 20 potentially new compounds and 11 new bioactive constituents found in Smilacis Glabrae Rhizoma utilizing HPLC‐DAD‐ESI‐IT‐TOF‐MSn. Phytochemical Analysis. 35(5). 1186–1196. 3 indexed citations
3.
Xu, Jingjing, Feng Xu, Wei Wang, et al.. (2022). Elucidation of the Mechanisms and Effective Substances of Paeoniae Radix Rubra Against Toxic Heat and Blood Stasis Syndrome With a Stage-Oriented Strategy. Frontiers in Pharmacology. 13. 842839–842839. 11 indexed citations
4.
Zhang, Yazhou, Feng Xu, Jing Dong, et al.. (2019). Profiling the metabolites of astrapterocarpan in rat hepatic 9000g supernatant. Chinese Journal of Natural Medicines. 17(11). 842–857. 7 indexed citations
5.
Wang, Jingzhe, Yifan Zhang, Feng Xu, et al.. (2018). Investigation of the in vivo metabolism of harpagoside and distribution of its metabolites in rats by HPLC‐IT‐TOF‐MSn. Biomedical Chromatography. 32(7). e4218–e4218. 7 indexed citations
6.
Yang, Xingxin, Yuzhen Zhou, Feng Xu, et al.. (2018). Screening potential mitochondria-targeting compounds from traditional Chinese medicines using a mitochondria-based centrifugal ultrafiltration/liquid chromatography/mass spectrometry method. Journal of Pharmaceutical Analysis. 8(4). 240–249. 12 indexed citations
7.
Yang, Xueyan, Yifan Zhang, Lijia Liu, et al.. (2017). Lignans and diterpenes isolated from Tirpitzia ovoidea and their biological activities. Chinese Journal of Natural Medicines. 15(12). 938–943. 4 indexed citations
8.
Xu, Feng, Ping Yang, Guang‐Xue Liu, et al.. (2017). Systematic screening and characterization of prototype constituents and metabolites of total astragalosides using HPLC-ESI-IT-TOF-MS n after oral administration to rats. Journal of Pharmaceutical and Biomedical Analysis. 142. 102–112. 22 indexed citations
9.
Xu, Feng, Dianpeng Li, Lei Wang, et al.. (2015). Exploring in vitro, in vivo metabolism of mogroside V and distribution of its metabolites in rats by HPLC-ESI-IT-TOF-MSn. Journal of Pharmaceutical and Biomedical Analysis. 115. 418–430. 61 indexed citations
11.
Huang, Shuai, Feng Xu, Ming‐Ying Shang, et al.. (2014). Improvement and Application of Acute Blood Stasis Rat Model Aligned with the 3Rs (Reduction, Refinement and Replacement) of Humane Animal Experimentation. Chinese Journal of Integrative Medicine. 26(4). 292–298. 1 indexed citations
13.
Wang, Chaoqun, Jinhuai Liu, Xiaowei Li, et al.. (2012). Comparative studies of saponins in 1–3-year-old main roots, fibrous roots, and rhizomes of Panax notoginseng, and identification of different parts and growth-year samples. Journal of Natural Medicines. 67(2). 339–349. 33 indexed citations
15.
Ge, Yue‐Wei, Shu Zhu, Ming‐Ying Shang, et al.. (2012). Aristololactams and aporphines from the stems of Fissistigma oldhamii (Annonaceae). Phytochemistry. 86. 201–207. 41 indexed citations
16.
Li, Xiaowei, Guang‐Xue Liu, Xuan Wang, et al.. (2012). Comparative study of the contents of analogues of aristolochic acid in two kinds of Aristolochiae Fructus by high-performance liquid chromatography. Journal of Natural Medicines. 67(1). 113–122. 13 indexed citations
17.
Meng, Liqiang, Yinghui Wang, Ming‐Ying Shang, et al.. (2011). Astragaloside IV synergizes with ferulic acid to inhibit renal tubulointerstitial fibrosis in rats with obstructive nephropathy. British Journal of Pharmacology. 162(8). 1805–1818. 65 indexed citations
18.
Wang, Rufeng, et al.. (2009). A new iridoid glycoside fromScrophularia ningpoensis. Natural Product Research. 23(13). 1181–1188. 24 indexed citations
19.
Xu, Feng, Yue Zhang, Shengyuan Xiao, et al.. (2006). ABSORPTION AND METABOLISM OF ASTRAGALI RADIX DECOCTION: IN SILICO, IN VITRO, AND A CASE STUDY IN VIVO. Drug Metabolism and Disposition. 34(6). 913–924. 85 indexed citations
20.
Shang, Ming‐Ying, Shao‐Qing Cai, S. Kadota, & Yasuhiro Tezuka. (2001). Structural identification of trigoneoside VIII. Yaoxue xuebao. 36(11). 836–839. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026